• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人铜蓝蛋白晶体结构的人凝血因子VIII三聚体A结构域的分子模型。

A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin.

作者信息

Pemberton S, Lindley P, Zaitsev V, Card G, Tuddenham E G, Kemball-Cook G

机构信息

Haemostasis Research Group, Medical Research Council Clinical Sciences Centre, London, UK.

出版信息

Blood. 1997 Apr 1;89(7):2413-21.

PMID:9116285
Abstract

The hemophilia A mutation database lists more than 160 missense mutations: each represents a molecular defect in the FVIII molecule, resulting in the X-linked bleeding disorder hemophilia A with a clinical presentation varying from mild to severe. Without a three-dimensional FVIII structure it is in most cases impossible to explain biological dysfunction in terms of the underlying molecular pathology. However, recently the crystal structure of the homologous human plasma copper-binding protein ceruloplasmin (hCp) has been solved, and the A domains of FVIII share approximately 34% sequence identity with hCp. This advance has enabled the building of a molecular model of the A domains of FVIII based on the sequence identity between the two proteins. The model allows exploration of predictions regarding the general features of the FVIII molecule, such as the binding-sites for factor IXa and activated protein C; it has also allowed the mapping of more than 30 selected mutations with known phenotype from the database, and the prediction of hypothetical links to dysfunction in all but a few cases. A computer-generated molecular model such as that reported here cannot substitute for a crystal structure. However, until such a structure for FVIII becomes available, the model represents a significant advance in modeling FVIII; it should prove a useful tool for exploiting the increasing amount of information in the hemophilia A mutation database, and for selecting appropriate targets for investigation of the structure-function relationships via mutagenesis and expression in vitro.

摘要

甲型血友病突变数据库列出了160多种错义突变:每一种都代表FVIII分子中的一种分子缺陷,导致X连锁出血性疾病甲型血友病,其临床表现从轻度到重度不等。由于缺乏FVIII的三维结构,在大多数情况下,不可能从潜在的分子病理学角度解释生物学功能障碍。然而,最近已解析出同源人类血浆铜结合蛋白铜蓝蛋白(hCp)的晶体结构,FVIII的A结构域与hCp具有约34%的序列同一性。这一进展使得能够基于两种蛋白质之间的序列同一性构建FVIII A结构域的分子模型。该模型有助于探索关于FVIII分子一般特征的预测,如与因子IXa和活化蛋白C的结合位点;它还能够对数据库中30多个具有已知表型的选定突变进行定位,并在除少数情况外的所有情况下预测与功能障碍的假设联系。像本文报道的这种计算机生成的分子模型不能替代晶体结构。然而,在FVIII的这种结构可用之前,该模型代表了FVIII建模方面的重大进展;它应该被证明是一种有用的工具,可用于利用甲型血友病突变数据库中越来越多的信息,以及通过体外诱变和表达来选择合适的靶点以研究结构 - 功能关系。

相似文献

1
A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin.基于人铜蓝蛋白晶体结构的人凝血因子VIII三聚体A结构域的分子模型。
Blood. 1997 Apr 1;89(7):2413-21.
2
Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.通过分子建模对人凝血因子V的A结构域进行结构研究。
Protein Sci. 1998 Jun;7(6):1317-25. doi: 10.1002/pro.5560070607.
3
Structure and function of the factor VIII gene and protein.凝血因子VIII基因和蛋白的结构与功能。
Semin Thromb Hemost. 2003 Feb;29(1):11-22. doi: 10.1055/s-2003-37935.
4
Proposed structure of the A domains of factor VIII by homology modelling.通过同源建模提出的凝血因子VIII A结构域的结构
Nat Struct Biol. 1995 Sep;2(9):740-4. doi: 10.1038/nsb0995-740.
5
The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4.凝血因子VIII结构与突变资源网站:HAMSTeRS第4版
Nucleic Acids Res. 1998 Jan 1;26(1):216-9. doi: 10.1093/nar/26.1.216.
6
Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII.凝血因子VIII的C结构域突变导致A型血友病的结构基础。
Thromb Haemost. 2000 Jan;83(1):78-85.
7
Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure.
Blood. 2000 Aug 1;96(3):979-87.
8
Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function.联合同源建模和错义突变在凝血因子 VIII 中的进化意义评估,以突出结构和功能方面。
Haemophilia. 2009 Jul;15(4):932-41. doi: 10.1111/j.1365-2516.2009.02009.x. Epub 2009 Apr 7.
9
3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography.膜结合凝血因子VIII的三维结构:在通过电子晶体学获得的三维密度图内对因子VIII异二聚体进行建模。
Blood. 2002 Feb 15;99(4):1215-23. doi: 10.1182/blood.v99.4.1215.
10
Factor VIII inhibitor with catalytic activity towards factor VIII.
Haematologica. 2000 Oct;85(10 Suppl):89-92.

引用本文的文献

1
Molecular Diagnosis of Hemophilia A and Pathogenesis of Novel F8 Variants in Shanxi, China.中国山西血友病A的分子诊断及新型F8变异体的发病机制
Glob Med Genet. 2023 Sep 13;10(3):247-262. doi: 10.1055/s-0043-1774322. eCollection 2023 Sep.
2
Factor VIII and Factor V Membrane Bound Complexes.VIII 因子和 V 因子膜结合复合物。
Subcell Biochem. 2021;96:153-175. doi: 10.1007/978-3-030-58971-4_2.
3
Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.
在凝血途径中,A2-A3界面处D666-S1787与T657-Y1792之间的稳定相互作用支持凝血因子VIIIa的稳定性。
J Thromb Haemost. 2016 May;14(5):1021-30. doi: 10.1111/jth.13292. Epub 2016 Mar 21.
4
Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings.凝血因子VIII在人内皮细胞中合成,包装在魏尔-帕拉德小体中,并与超大血管性血友病因子链结合分泌。
PLoS One. 2015 Oct 16;10(10):e0140740. doi: 10.1371/journal.pone.0140740. eCollection 2015.
5
Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes.与脂质纳米管结合的血液凝固因子VIII的二聚体结构
Sci Rep. 2015 Jun 17;5:11212. doi: 10.1038/srep11212.
6
Ceruloplasmin has two nearly identical sites that bind myeloperoxidase.铜蓝蛋白有两个结合髓过氧化物酶的几乎相同的位点。
Biochem Biophys Res Commun. 2014 Oct 31;453(4):722-7. doi: 10.1016/j.bbrc.2014.09.134. Epub 2014 Oct 6.
7
Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.将因子VIII的天冬氨酸519和谷氨酸665替换为缬氨酸对其在体内血浆存活时间和疗效的影响。
AAPS J. 2014 Sep;16(5):1038-45. doi: 10.1208/s12248-014-9627-2. Epub 2014 Jun 17.
8
Enhanced factor VIIIa stability of A2 domain interface variants results from an increased apparent affinity for the A2 subunit. Results from an increased apparent affinity for the A2 subunit.A2结构域界面变体的凝血因子VIIIa稳定性增强源于对A2亚基的表观亲和力增加。源于对A2亚基的表观亲和力增加。
Thromb Haemost. 2014 Sep 2;112(3):495-502. doi: 10.1160/TH14-01-0086. Epub 2014 Jun 5.
9
Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.凝血途径中因子VIIIa的辅因子活性通过因子VIII中His281和Ser524之间形成的结构域间键得以稳定。
J Biol Chem. 2014 May 16;289(20):14020-9. doi: 10.1074/jbc.M114.550566. Epub 2014 Apr 1.
10
Blood Clotting Factor VIII: From Evolution to Therapy.凝血因子 VIII:从进化到治疗。
Acta Naturae. 2013 Apr;5(2):19-39.